Canoy, Romeo N.
HRN: 24-04-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CEFUROXIME 1.5GM (VIAL)
01/04/2024
01/11/2024
IV
1.5g
Q8hrs PTOR
Cholelithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes